Invasive T1 bladder cancer: Indications and rationale for radical cystectomy

BJU International

Volumn 102, Issue 3, 2008, Pages 270-275

  Stein, John P ^a   Penson, David F ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Lamina propria; Surgery; Transitional cell carcinoma; Urothelial tumour

Indexed keywords

BCG VACCINE;

BLADDER CANCER; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONSERVATIVE TREATMENT; CYSTECTOMY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT INDICATION;

CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 47649129121     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07743.x     Document Type: Review

References (37)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2005. CA Cancer J Clin 2006 56 : 106 30
2. Herr HW. Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin. J Urol 1991 145 : 40 2
3. Pansadoro V, Emiliozzi P, Defidio L et al. Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results. J Urol 1995 154 : 2054 9
4. Pham HT, Soloway MS. High-risk superficial bladder cancer: intravesical therapy for T1, G3 transitional cell carcinoma of the urinary bladder. Semin Urol Oncol 1997 15 : 147 53
5. Peyromaure M, Guerin F, Amsellem-Ouazana D et al. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. J Urol 2003 169 : 2110 2
6. Shahin O, Thalmann GN, Rentsch C, Mazzuccchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus calmette-guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 2003 169 : 96 100
7. Herr HW. Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 2005 32 : 157 64
8. Lamm DL, Blumenstein BA, Crissman JD et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder; a randomized Southwest Oncology Group Study. J Urol 2000 158 : 62 7
9. Stein JP. Indications for early cystectomy. Urology 2003 62 : 591 3
10. Cookson MS, Herr HW, Zhang ZF, Soloway S, Sogani PC, Fair WR. The treated natural history of high risk superficial bladder cancer: 15 year outcome. J Urol 1997 158 : 62 7
11. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001 19 : 666 75
12. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994 73 : 1926 31
13. Pagano F, Bassi P, Galetti TP et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J Urol 1991 145 : 45 50
14. Freeman JA, Esrig D, Stein JP et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995 76 : 833 9
15. Amling CL, Trasher JB, Frazier HA et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 1994 151 : 31 5
16. Yiou R, Patard JJ, Benhard H, Abbou CC, Chopin DK. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. BJU Int 2002 89 : 374 8
17. Wisner C, Pfitzenmaier J, Faldum A, Gillitzer R, Melchior SW, Thuroff JW. Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections an tumour upstaging at radical cystectomy. BJU Int 2005 95 : 301 5
18. Bianco FJ Jr, Justa D, Grignon DJ, Sakr WA, Pontes JE, Wood DP. Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. Urol Oncol 2004 22 : 290 4
19. Solsona E, Iborra I, Rubio J, Casanova J, Almenar S. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 2004 94 : 1258 62
20. Nieder AM, Simon MA, Kim SS, Manoharan M, Soloway MS. Radical cystectomy after bacillus Calmette-Guerin for high-risk Ta, T1, an carcinoma in situ: defining the risk of initial bladder preservation. Urology 2006 67 : 737 41
21. Huguet J, Crego M, Sabate S, Salvador J, Palou J, Villavicencio H. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 2005 48 : 53 9
22. Herr HW, Donat SM. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. J Urol 1999 161 : 1854
23. Stockle M, Alken P, Englemann U, Jacobi GH, Riedmiller H, Hohenfellner R. Radical cystectomy- often too late? Eur Urol 1987 13 : 361 7
24. Herr HW, Sogani PC. Does early cystectomy improve the survival of patient with high risk superficial bladder tumors. J Urol 2001 166 : 12960 1299
25. Masood S, Sriprasad S, Palmer JH et al. T1G3 bladder cancer - indications for early cystectomy. Int Urol Nephrol 2004 36 : 41 4
26. Orsola A, Trias I, Raventos CX et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-Non-treated patients. Eur Urol 2005 48 : 231 8
27. Holmang S, Hedelin H, Anderstrom C, Holmberg E, Johansson SL. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol 1997 157 : 800 3
28. Smits G, Schaafsma E, Kiemeney L, Caris C, Debruyne F, Witjes JA. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression. Urology 1998 52 : 1009 13
29. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patient with T1 bladder carcinoma. J Clin Oncol 1999 17 : 3182 7
30. Kondylis FI, Demirci S, Ladaga L, Kolm P, Schellhammer PF. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000 163 : 1120 3
31. Epstein JI, Amin MB, van Reuter R et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasm of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Path 1998 22 : 1435 48
32. Dalbagni G, Herr HW, Reuter VE. Impact of second transurethral resection on the staging of T1 bladder cancer. Urology 2002 60 : 822
33. Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007 177 : 75 9
34. Pan C-X, Zhang H, Lara PN, Cheng L. Small-cell carcinoma of the urinary bladder: diagnosis and management. Exper Rev Anticancer Ther 2006 6 : 1707 13
35. Kamat AM, Gee JR, Dinney CP et al. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol 2006 175 : 881 5
36. Quek ML, Stein JP, Nichols PW et al. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy. J Urol 2005 174 : 103 6
37. Raj G, Herr H, Serio AM et al. Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 2007 177 : 1283 6